featured
Minimal Residual Disease Detection Using a Plasma-Only ctDNA Assay in Patients With Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Minimal Residual Disease Detection Using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients
Clin. Cancer Res 2021 Apr 29;[EPub Ahead of Print], AR Parikh, EE Van Seventer, G Siravegna, AV Hartwig, A Jaimovich, Y He, K Kanter, M Fish, KD Fosbenner, B Miao, S Phillips, JH Carmichael, N Sharma, J Jarnagin, I Baiev, YS Shah, IJ Fetter, HA Shahzade, JN Allen, LS Blaszkowsky, JW Clark, JS Dubois, JW Franses, B Giantonio, L Goyal, SJ Klempner, RD Nipp, EJ Roeland, DP Ryan, CD Weekes, JY Wo, TS Hong, L Bordeianou, CR Ferrone, M Qadan, H Kunitake, D Berger, R Ricciardi, JC Cusack, VM Raymond, A Talasaz, GM Boland, RB CorcoranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.